Strelia advised Newton Biocapital on the deal.Newton Biocapital acted as lead investor in the 20 million series A investment round in NeuVasQ Biotechnologies, a spin-off of the…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
